BioTelemetry (BEAT) Tops Q1 EPS by 1c

BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $40.95 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Melco Resorts & Entertainment (MLCO) Misses Q2 EPS by 7c
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance